Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Biodesix Inc
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Services-Medical Laboratories
Prev close 27.18 · gapped below the open, then crossed back over prior close. High/low 27.70 at 5:30 pm ET, 26.76 at 12:15 pm ET.
Biodesix Inc has 5 disclosed suppliers and 1 disclosed customer. Each one is named in an SEC filing, either Biodesix Inc’s own annual report or the counterparty’s, and carries the sentence that discloses it.
Sources
sec edgar · verbatim disclosureEach tie, with the sentence that disclosed it. Open a row for the wording and the filing it came from.
“For the years ended December 31, 2025 and 2024, Medicare reimbursed 32% and 39%, respectively, of our total revenue to us.”
$28M relationship
basisBDSX fy2025 · closed 2025-12 $88M
FILING10-K0001193125-26-076547cik 0001439725
“Bio-Rad, as described below, is the sole source supplier for our GeneStrat test.”
FILING10-K0001193125-26-076547cik 0001439725
“Freenome is also the sole source supplier for our Nodify CDT tests but there are known secondary suppliers for these materials.”
FILING10-K0001193125-26-076547cik 0001439725
“On April 22, 2024, the Company obtained consent from Perceptive and prepaid the July 1, 2024 contingent consideration milestone payment of $8.4 million to Integrated Diagnostics (Indi).”
FILING10-K0001193125-26-076547cik 0001439725
“Included under the PCA was (a) an APA whereby we acquired all of the United States assets associated with the De Soto, Kansas clinical laboratory, as well as the trademarks and patent application associated with the test; (b) an intellectual property license granting us the rights necessary under Oncimmune's background intellectual property rights to perform the Nodify CDT test; (c) a supply agreement for supplying us with the necessary materials and reagents needed to run the Nodify CDT test; and (d) a development agreement where Oncimmune agrees to assist us in further developing the Nodify CDT test.”
FILING10-K0001193125-26-076547cik 0001439725
“On November 21, 2022, the Company entered into a Credit Agreement and Guaranty (the Credit Agreement) with Perceptive Credit Holdings IV, LP (Perceptive) as lender and administrative agent (the Lender) for up to $50.0 million, with funding of $30.0 million and the issuance of warrants exercisable into 150,000 shares of the Company's common stock occurring on November 21, 2022, and two additional contingently issuable tranches of $10.0 million each subject to certain terms and conditions, including revenue milestones.”
FILING10-K0001193125-26-076547cik 0001439725
Watchlist prices, news filtered to it, and its next report on your desk.
BDSX (Biodesix Inc) has 5 disclosed suppliers and 1 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.